Virtu Financial LLC Glaukos Corp Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 17, 2022	SELL	$40.27 - $56.99 $240,210 - $339,945	-5,965 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $282,919 - $502,431	5,965 New	5,965 $287,000
Q3 2019 Nov 20, 2019	SELL	$58.58 - $83.91 $210,536 - $301,572	-3,594 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$63.59 - $78.71 $679,014 - $840,465	-10,678 Reduced 74.82%	3,594 $271,000
Q1 2019 Apr 12, 2019	BUY	$50.75 - $80.54 $522,623 - $829,400	10,298 Added 259.13%	14,272 $1.12 Million
Q4 2018 Jan 16, 2019	BUY	$52.18 - $67.93 $207,363 - $269,953	3,974 New	3,974 $223,000

342

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.49B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.